Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 7Papillomavirus Infections 6Neoplasms 5Breast Neoplasms 4Uterine Cervical Dysplasia 3Melanoma 3Lung Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Vulvar Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Anus Neoplasms 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Sarcoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Persistent Infection 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Nasopharyngeal Neoplasms 1

Interventions

napabucasin 3Irinotecan 3Gemcitabine 3Bevacizumab 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3entinostat 2Paclitaxel 2Leucovorin 2Fluorouracil 2sipuleucel-T 1pralsetinib 1pembrolizumab 1luprolide acetate gel depot 1lenvatinib 1interferon gamma-1b 1ficlatuzumab 1catumaxomab 1Vaccines 1Papillomavirus Vaccines 1Oncolytic Virotherapy 1Ocoxin 1Nivolumab 1Leuprolide 1Interferon-gamma 1Immunotherapy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gefitinib 1Filgrastim 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Glandular and Epithelial × Vaccines × Clear all
NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡